Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. Cardio was formed to further develop and commercialize a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become one of the leading medical technology companies for enabling improved prevention, early detection, and assists in treatment of cardiovascular disease.
Company profile
Ticker
CDIO, CDIOW
Exchange
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Mana Capital Acquisition Corp.
SEC CIK
Corporate docs
IRS number
870925574
CDIO stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
22 Mar 23
8-K
Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million
13 Mar 23
EFFECT
Notice of effectiveness
25 Jan 23
424B3
Prospectus supplement
24 Jan 23
CORRESP
Correspondence with SEC
20 Jan 23
S-1/A
IPO registration (amended)
13 Jan 23
S-1/A
IPO registration (amended)
27 Dec 22
UPLOAD
Letter from SEC
22 Dec 22
S-1
IPO registration
12 Dec 22
8-K
Changes in Registrant's Certifying Accountant
10 Nov 22
Latest ownership filings
SC 13G/A
Space Summit Capital LLC
8 Feb 23
SC 13G/A
Weiss Asset Management LP
6 Feb 23
SC 13D
Philibert Robert
4 Nov 22
3
Robert Philibert
4 Nov 22
SC 13D
Dogan Meeshanthini
3 Nov 22
3
Brandon Sim
3 Nov 22
3
Warren Hosseinion
3 Nov 22
3
Timur Dogan
3 Nov 22
3
Meeshanthini Dogan
3 Nov 22
3
Khullani Abdullahi
3 Nov 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 177.68 k | 177.68 k | 177.68 k | 177.68 k | 177.68 k | 177.68 k |
Cash burn (monthly) | (no burn) | 29.08 k | (no burn) | 55.67 k | (no burn) | 36.37 k |
Cash used (since last report) | n/a | 172.70 k | n/a | 330.60 k | n/a | 215.98 k |
Cash remaining | n/a | 4.98 k | n/a | -152.92 k | n/a | -38.29 k |
Runway (months of cash) | n/a | 0.2 | n/a | -2.7 | n/a | -1.1 |
Institutional ownership, Q4 2022
21.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 35 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 6.00 k |
Total shares | 2.09 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Mana Capital | 1.57 mm | $0.00 |
Space Summit Capital | 400.00 k | $0.00 |
Context Capital Management | 121.50 k | $6.00 k |
Feis Lawrence Michael | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Oct 22 | Mana Capital | Common Stock, par value $0.00001 per share | Other | Dispose J | No | No | 0 | 1,565,000 | 0.00 | 0 |
25 Oct 22 | Mana Capital | Private Warrant Common Stock | Other | Dispose J | No | No | 11.5 | 2,500,000 | 28.75 mm | 0 |
News
12 Health Care Stocks Moving In Wednesday's Intraday Session
22 Mar 23
12 Health Care Stocks Moving In Tuesday's Intraday Session
14 Mar 23
12 Health Care Stocks Moving In Monday's Intraday Session
6 Mar 23
12 Health Care Stocks Moving In Friday's After-Market Session
3 Mar 23
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
2 Mar 23
Press releases
Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million
8 Mar 23
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy
8 Mar 23
Thinking about buying stock in OncoSec Medical, Diversified Healthcare, Cardio Diagnostics, Plug Power, or Macy's?
2 Mar 23
Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application
2 Mar 23
Thinking about buying stock in AMC Entertainment, Cardio Diagnostics, Lucira Health, Meta Platforms, or Clover Health?
28 Feb 23